For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Levetiracetam (Anticonvulsant (SV2A ligand)) – indications: Status epilepticus – adults (2nd line, after benzodiazepine), Status epilepticus – children (2nd line, after benzodiazepine). Weight-based dosing in mg and ml in the app, with sources.
Indications
- Status epilepticus – adults (2nd line, after benzodiazepine)
- Status epilepticus – children (2nd line, after benzodiazepine)
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Sources and guidelines
- Rosenow F, Weber J et al. S2k-Leitlinie Status epilepticus im Erwachsenenalter. Deutsche Gesellschaft für Neurologie gemeinsam mit der Österreichischen Gesellschaft für Neurologie (ÖGN), 2020; AWMF-Register 030-079, korrigierte Registerfassung 03/2022, gültig bis 29.06.2025.
- Djakow J, Turner NM, Skellett S et al. European Resuscitation Council Guidelines 2025 Paediatric Life Support. Resuscitation 2025;215 Suppl 1:110767.